Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

e-Poster Display Session

94P - Prognostic influence of mean platelet volume on stage III rectal cancer patients: A tertiary cancer center study

Date

22 Nov 2020

Session

e-Poster Display Session

Topics

Tumour Site

Colon and Rectal Cancer

Presenters

Pavan Jonnada

Citation

Annals of Oncology (2020) 31 (suppl_6): S1273-S1286. 10.1016/annonc/annonc355

Authors

P.K. Jonnada, R. Arjunan, U. Karjol, A. Syed, A. Chandranath, A.Z. Anwar

Author affiliations

  • Surgical Oncology, kidwai memorial institute of oncology, 560029 - Banglore/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 94P

Background

Mean platelet volume (MPV) is a marker of inflammation that indicates the average size of platelets, platelet production rate and stimulation. The role of Pre-operative levels of MPV and its prognostic effect on disease free survival (DFS) and overall survival (OS) are poorly understood. This study was intended to analyze the effect of pre-operative levels of MPV on DFS and OS of stage III rectal cancer patients.

Methods

This is a retrospective study of 149 stage III rectal cancer patients who underwent surgery in our institution between 2011 and 2015. Association between pre-operative levels of MPV and clinicopathological variables were analysed. DFS and OS for 5 years were analysed, and survival analysis was done using Kaplan-Meier curve. MPV of 9.35 femto litres (fl) was chosen based on the ROC curve. The Area under curve was 0.889. Differences between survival curves were analysed for statistical significance using log-rank test.

Results

In our study, mean 5-year OS were 91.1 and 50.36 months, for patients with MPV < 9.35 and MPV >9.35 respectively (P 0.0001). The mean DFS of MPV < 9.35 and MPV > 9.35 were 89.32 and 43.54 months respectively (P 0.0001). Univariate analysis for OS and DFS showed significance for MPV, Nodal status, Circumferential resection margin, stage and lymph node ratio. Multivariate analysis showed significance for MPV [HR 2.379 (95% CI 1.733-3.264) P .0001 for MPV>9.35] and CRM [HR 0.392 (95% CI 0.191-0.804) P 0.01) for CRM negative] for OS and DFS. Multivariate Analysis for OS & DFS Table: 94P

Variable OS DFS
P value Hazard Ratio 95% CI P value Hazard Ratio 95% CI
Lower Upper Lower Upper
N Stage
N1a .782 .785 .140 4.390 .824 .833 .167 4.146
N1b .119 .322 .077 1.340 .159 .389 .104 1.448
N2a .554 .715 .235 2.175 .680 .810 .297 2.209
N2b Reference Reference
CRM
Negative .011 .392 .191 .804 .012 .412 .207 .821
Positive Reference Reference
Stage
IIIA .568 .692 .196 2.447 .203 .465 .143 1.510
IIIB .474 .727 .303 1.743 .203 .607 .281 1.310
IIIC Reference Reference
MPV
>9.35 .0001 2.379 1.733 3.264 .0001 2.370 1.791 3.136
<9.35 Reference Reference
LNR ratio
>0.2 .220 3.269 .492 21.738 .059 5.756 .938 35.327
<0.2 Reference Reference
.

Conclusions

Pre-operative MPV measured one week before surgery is a convenient and inexpensive marker which has been proved to be a prognostic marker for OS and DFS in stage III rectal cancer patients.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Kidwai Memorial Institute of Oncology, Bangalore, India.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.